Clinical Trial Update: Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients [Phase 2]

View source ↗

Summary

Clinical trial update comparing pharmacokinetics of LCP-Tacro given once daily versus Prograf given twice daily in adult de novo liver transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Drugs mentioned

• LCP-Tacro (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Veloxis Pharmaceuticals | Conditions: Liver Failure | Phase 2 | Status: COMPLETED | Results posted: 2015-06-25